A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting | Zendy

AI Assistant Blog Pricing

A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.